Using power Doppler ultrasound to improve needle localization during prostate brachytherapy
Needle Localization During Prostate Brachytherapy Using Power Doppler Ultrasound
This study is testing whether using power Doppler ultrasound can help doctors place needles more accurately during prostate cancer treatment.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 20 (estimated) |
| Ages | 18 Years and up |
| Sex | Male |
| Sponsor | Western University, Canada Academic / other |
| Locations | 1 site (London, Ontario) |
| Trial ID | NCT03861507 on ClinicalTrials.gov |
What this trial studies
This study focuses on patients scheduled for standard brachytherapy treatment for prostate cancer. It aims to enhance the visualization of needle placement by utilizing power Doppler ultrasound in conjunction with a simple oscillator attached to the brachytherapy needle. The vibrations transmitted through the needle are expected to be captured by the ultrasound, providing better guidance during the procedure. This innovative approach seeks to improve the accuracy of needle localization compared to traditional 2D ultrasound methods.
Who should consider this trial
Good fit: Ideal candidates are males aged 18 years or older with pathologically confirmed prostate cancer who are suitable for high-dose-rate brachytherapy.
Not a fit: Patients who have previously received radiotherapy to the prostate may not benefit from this study.
Why it matters
Potential benefit: If successful, this method could lead to more precise brachytherapy treatments, potentially improving patient outcomes and reducing complications.
How similar studies have performed: While this approach is innovative, similar studies using advanced imaging techniques in brachytherapy have shown promise in improving treatment accuracy.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male, aged 18 years or older * Willing to provide written consent * Pathologically confirmed prostate cancer on previous biopsy * Suitable for and consenting to high-dose-rate brachytherapy for treatment as standard of care. Exclusion Criteria: * • Previous radiotherapy to the prostate
Where this trial is running
London, Ontario
- Victoria Hospital — London, Ontario, Canada (Recruiting)
Study contacts
- Study coordinator: Aaron Fenster
- Email: afenster@uwo.ca
- Phone: 5199315777
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.